Table 1: Description of the different groups of patients according to their gastrostomy placement modalities.
|
PEG-B |
PEG-T |
p |
SG-B |
p |
|
|
Number of patients |
63 |
58 |
83 |
||
|
Sex ratio (M:F) |
2.1 |
1.3 |
1.7 |
||
|
Median age (years) |
5.5 [0.4-15.6] |
3.4 [0.3-15.6] |
0.58 |
1.5 [0.0-15.7] |
< 0.01 |
|
Median weight (Kg) |
16.3 [5.4-54.0] |
13.8 [4.3-62.0] |
0.26 |
7.8 [1.2-85.0] |
< 0.01 |
|
Neurologic impairment/metabolic issues |
38 (60.3%) |
22 (37.9%) |
0.02 |
58 (69.9%) |
0.29 |
|
Malformative conditions |
7 (11.1%) |
14 (24.2%) |
0.09 |
27 (32.5%) |
< 0.01 |
|
Oncological issue |
18 (28.6%) |
22 (37.9%) |
0.33 |
0 (0%) |
< 0.01 |
|
Under nutrition (n (%)) |
31/57 (54%) |
27/43 (63%) |
0.54 |
35/70 (50%) |
0.59 |
|
Immunosuppression (n (%)) |
17 (27%) |
10 (18%) |
0.28 |
1 (1%) |
< 0.01 |
|
PPI (n (%)) |
22 (41%) |
31 (70%) |
< 0.01 |
45 (69%) |
0.01 |
|
Associated fundoplication (n (%)) |
0 |
0 |
75 (90%) |
< 0.01 |
Data for the SG-T group have been given for information only and did not differ from the SG-B group. Statistical analysis has been made for groups PEG-T and group SG-B respectively, as compared to group PEG-B. Quantitative variables were summarized using: Median [Inter-Quartile Range (IQR)]. PPI: proton pump inhibitors.